It was reported through the patient outcome, the patient passed away due to covid, right heart failure, sepsis, and shock.
|
Manufacturer's investigation conclusion: a specific cause for the reported event could not be conclusively determined through this evaluation, and a direct correlation with heartmate ii left ventricular assist system (lvas), serial number (b)(6), could not be conclusively established.The patient expired on (b)(6)2020 due to covid-19, right heart failure, sepsis, and shock.The source of the infection was reportedly covid-19, and the patient was treated with inotropes, oxygen, and steroids.It was reported that there were no device issues and the device operated as expected.Heartmate ii lvas, serial number (b)(6), will reportedly not be returned for evaluation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit shipped on (b)(6)2017.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu) is currently available.Section 1 ¿introduction¿ of this document lists local infection, sepsis, right heart failure, and death as adverse events that may be associated with the use of heartmate ii lvas.Section 6 ¿patient care and management¿ includes information regarding how to prevent and control infection.Section 6 (under "right heart failure") discusses the potential development of right heart failure during use of the heartmate ii lvas and outlines the associated treatment options.The heartmate ii lvas patient handbook contains several sections with information about how to prevent and control infection.No further information was provided.The manufacturer is closing the file on this event.
|